Viral Inactivation of Intramuscular Immune Serum Globulins
A new process for the production of intramuscular immunoglobulin products is described which includes viral inactivation through solvent-detergent treatment. Removal of solvent-detergent was accomplished by precipitation, filtration and diafiltration. Process-scale preparations had appropriate antib...
Gespeichert in:
| Veröffentlicht in: | Biologicals 2000-03, Vol.28 (1), p.5-15 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 15 |
|---|---|
| container_issue | 1 |
| container_start_page | 5 |
| container_title | Biologicals |
| container_volume | 28 |
| creator | Alonso, William R. Trukawinski, Susan Savage, Margaret Tenold, Robert A. Hammond, David J. |
| description | A new process for the production of intramuscular immunoglobulin products is described which includes viral inactivation through solvent-detergent treatment. Removal of solvent-detergent was accomplished by precipitation, filtration and diafiltration. Process-scale preparations had appropriate antibody potency levels, and improved IgG integrity relative to traditional IGIM products. Moreover, acceptable results were obtained in all in vitro and in vivo pre-clinical toxicology testing, as well as clinical evaluation. Scaled-down experiments demonstrated that the new process provides effective viral inactivation. Taken together, these results indicate that the new products should have the same efficacy of the previous IGIM products albeit with safety and processing improvements. |
| doi_str_mv | 10.1006/biol.1999.0234 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17522111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1045105699902348</els_id><sourcerecordid>17522111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-f545eece0694adf4909286a0f1d3fe51c2f4a595482762aa7c5fab0411af59913</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMorq5ePUpP3lpn2qTdeJNF14UFD35cQ5pOINKPNWkX_Pe2dA9ePM0MPO8L8zB2g5AgQH5fuq5OUEqZQJrxE3aBIEW8ylI4nXYuYgSRL9hlCF8AiLzg52yBUEgJAi7Yw6fzuo62rTa9O-jedW3U2fHuvW6GYIZa-2jbNENL0Rv5oYk2dVcOtWvDFTuzug50fZxL9vH89L5-iXevm-36cRebrMA-toILIkOQS64ryyXIdJVrsFhllgSa1HItpOCrtMhTrQsjrC6BI2orpMRsye7m3r3vvgcKvWpcMFTXuqVuCAoLkaaIE5jMoPFdCJ6s2nvXaP-jENRkS0221GRLTbbGwO2xeSgbqv7gs54RWM0Ajf8dHHkVjKPWUOU8mV5Vnfuv-xdjiHiT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17522111</pqid></control><display><type>article</type><title>Viral Inactivation of Intramuscular Immune Serum Globulins</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Alonso, William R. ; Trukawinski, Susan ; Savage, Margaret ; Tenold, Robert A. ; Hammond, David J.</creator><creatorcontrib>Alonso, William R. ; Trukawinski, Susan ; Savage, Margaret ; Tenold, Robert A. ; Hammond, David J.</creatorcontrib><description>A new process for the production of intramuscular immunoglobulin products is described which includes viral inactivation through solvent-detergent treatment. Removal of solvent-detergent was accomplished by precipitation, filtration and diafiltration. Process-scale preparations had appropriate antibody potency levels, and improved IgG integrity relative to traditional IGIM products. Moreover, acceptable results were obtained in all in vitro and in vivo pre-clinical toxicology testing, as well as clinical evaluation. Scaled-down experiments demonstrated that the new process provides effective viral inactivation. Taken together, these results indicate that the new products should have the same efficacy of the previous IGIM products albeit with safety and processing improvements.</description><identifier>ISSN: 1045-1056</identifier><identifier>EISSN: 1095-8320</identifier><identifier>DOI: 10.1006/biol.1999.0234</identifier><identifier>PMID: 10799050</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antibodies, Bacterial ; Antibodies, Viral ; Antiviral Agents - pharmacology ; Cell Line ; Consumer Product Safety ; Drug Contamination - prevention & control ; HIV-1 - drug effects ; HIV-1 - growth & development ; Humans ; Immunoglobulins ; Organophosphates - pharmacology ; Sodium Cholate - pharmacology</subject><ispartof>Biologicals, 2000-03, Vol.28 (1), p.5-15</ispartof><rights>2000 The International Association for Biologicals</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-f545eece0694adf4909286a0f1d3fe51c2f4a595482762aa7c5fab0411af59913</citedby><cites>FETCH-LOGICAL-c371t-f545eece0694adf4909286a0f1d3fe51c2f4a595482762aa7c5fab0411af59913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/biol.1999.0234$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10799050$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alonso, William R.</creatorcontrib><creatorcontrib>Trukawinski, Susan</creatorcontrib><creatorcontrib>Savage, Margaret</creatorcontrib><creatorcontrib>Tenold, Robert A.</creatorcontrib><creatorcontrib>Hammond, David J.</creatorcontrib><title>Viral Inactivation of Intramuscular Immune Serum Globulins</title><title>Biologicals</title><addtitle>Biologicals</addtitle><description>A new process for the production of intramuscular immunoglobulin products is described which includes viral inactivation through solvent-detergent treatment. Removal of solvent-detergent was accomplished by precipitation, filtration and diafiltration. Process-scale preparations had appropriate antibody potency levels, and improved IgG integrity relative to traditional IGIM products. Moreover, acceptable results were obtained in all in vitro and in vivo pre-clinical toxicology testing, as well as clinical evaluation. Scaled-down experiments demonstrated that the new process provides effective viral inactivation. Taken together, these results indicate that the new products should have the same efficacy of the previous IGIM products albeit with safety and processing improvements.</description><subject>Antibodies, Bacterial</subject><subject>Antibodies, Viral</subject><subject>Antiviral Agents - pharmacology</subject><subject>Cell Line</subject><subject>Consumer Product Safety</subject><subject>Drug Contamination - prevention & control</subject><subject>HIV-1 - drug effects</subject><subject>HIV-1 - growth & development</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Organophosphates - pharmacology</subject><subject>Sodium Cholate - pharmacology</subject><issn>1045-1056</issn><issn>1095-8320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LxDAQhoMorq5ePUpP3lpn2qTdeJNF14UFD35cQ5pOINKPNWkX_Pe2dA9ePM0MPO8L8zB2g5AgQH5fuq5OUEqZQJrxE3aBIEW8ylI4nXYuYgSRL9hlCF8AiLzg52yBUEgJAi7Yw6fzuo62rTa9O-jedW3U2fHuvW6GYIZa-2jbNENL0Rv5oYk2dVcOtWvDFTuzug50fZxL9vH89L5-iXevm-36cRebrMA-toILIkOQS64ryyXIdJVrsFhllgSa1HItpOCrtMhTrQsjrC6BI2orpMRsye7m3r3vvgcKvWpcMFTXuqVuCAoLkaaIE5jMoPFdCJ6s2nvXaP-jENRkS0221GRLTbbGwO2xeSgbqv7gs54RWM0Ajf8dHHkVjKPWUOU8mV5Vnfuv-xdjiHiT</recordid><startdate>20000301</startdate><enddate>20000301</enddate><creator>Alonso, William R.</creator><creator>Trukawinski, Susan</creator><creator>Savage, Margaret</creator><creator>Tenold, Robert A.</creator><creator>Hammond, David J.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20000301</creationdate><title>Viral Inactivation of Intramuscular Immune Serum Globulins</title><author>Alonso, William R. ; Trukawinski, Susan ; Savage, Margaret ; Tenold, Robert A. ; Hammond, David J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-f545eece0694adf4909286a0f1d3fe51c2f4a595482762aa7c5fab0411af59913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Antibodies, Bacterial</topic><topic>Antibodies, Viral</topic><topic>Antiviral Agents - pharmacology</topic><topic>Cell Line</topic><topic>Consumer Product Safety</topic><topic>Drug Contamination - prevention & control</topic><topic>HIV-1 - drug effects</topic><topic>HIV-1 - growth & development</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Organophosphates - pharmacology</topic><topic>Sodium Cholate - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alonso, William R.</creatorcontrib><creatorcontrib>Trukawinski, Susan</creatorcontrib><creatorcontrib>Savage, Margaret</creatorcontrib><creatorcontrib>Tenold, Robert A.</creatorcontrib><creatorcontrib>Hammond, David J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Biologicals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alonso, William R.</au><au>Trukawinski, Susan</au><au>Savage, Margaret</au><au>Tenold, Robert A.</au><au>Hammond, David J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Viral Inactivation of Intramuscular Immune Serum Globulins</atitle><jtitle>Biologicals</jtitle><addtitle>Biologicals</addtitle><date>2000-03-01</date><risdate>2000</risdate><volume>28</volume><issue>1</issue><spage>5</spage><epage>15</epage><pages>5-15</pages><issn>1045-1056</issn><eissn>1095-8320</eissn><abstract>A new process for the production of intramuscular immunoglobulin products is described which includes viral inactivation through solvent-detergent treatment. Removal of solvent-detergent was accomplished by precipitation, filtration and diafiltration. Process-scale preparations had appropriate antibody potency levels, and improved IgG integrity relative to traditional IGIM products. Moreover, acceptable results were obtained in all in vitro and in vivo pre-clinical toxicology testing, as well as clinical evaluation. Scaled-down experiments demonstrated that the new process provides effective viral inactivation. Taken together, these results indicate that the new products should have the same efficacy of the previous IGIM products albeit with safety and processing improvements.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>10799050</pmid><doi>10.1006/biol.1999.0234</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1045-1056 |
| ispartof | Biologicals, 2000-03, Vol.28 (1), p.5-15 |
| issn | 1045-1056 1095-8320 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_17522111 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Antibodies, Bacterial Antibodies, Viral Antiviral Agents - pharmacology Cell Line Consumer Product Safety Drug Contamination - prevention & control HIV-1 - drug effects HIV-1 - growth & development Humans Immunoglobulins Organophosphates - pharmacology Sodium Cholate - pharmacology |
| title | Viral Inactivation of Intramuscular Immune Serum Globulins |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Viral%20Inactivation%20of%20Intramuscular%20Immune%20Serum%20Globulins&rft.jtitle=Biologicals&rft.au=Alonso,%20William%20R.&rft.date=2000-03-01&rft.volume=28&rft.issue=1&rft.spage=5&rft.epage=15&rft.pages=5-15&rft.issn=1045-1056&rft.eissn=1095-8320&rft_id=info:doi/10.1006/biol.1999.0234&rft_dat=%3Cproquest_cross%3E17522111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17522111&rft_id=info:pmid/10799050&rft_els_id=S1045105699902348&rfr_iscdi=true |